Table 1 The correlation between vasculogenic mimicry formation with clinicopathological features in 50 glioblastoma samples.
From: Tenascin-c mediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma
 | No. | VM | χ2 | p-value | |
---|---|---|---|---|---|
Positive | Negative | ||||
Sex | |||||
Male | 33 | 14 | 19 | 3.07 | 0.117a |
Female | 17 | 3 | 14 | Â | Â |
Age (years) | |||||
<50 | 27 | 8 | 19 | 0.5 | 0.557a |
≥50 | 23 | 9 | 14 |  |  |
Tumor size (diameter) | |||||
<5 | 21 | 10 | 11 | 2.993 | 0.131a |
≥5 | 29 | 7 | 22 |  |  |
IDH | |||||
Yes | 7 | 3 | 4 | 0.011 | 0.9182b |
No | 43 | 14 | 29 | Â | Â |
MGMT | |||||
Yes | 25 | 10 | 15 | 0.802 | 0.370a |
No | 25 | 7 | 18 | Â | Â |
Preoperative epilepsy | |||||
Yes | 10 | 4 | 6 | 0.006 | 0.941b |
No | 40 | 13 | 27 | Â | Â |
MVD | |||||
<median | 28 | 5 | 23 | 7.39 | 0.007a |
>median | 22 | 12 | 10 | Â | Â |
Extent of tumor resection | |||||
Gross total/subtotal | 38 | 13 | 25 | 0.000 | 1.000b |
Partial | 12 | 4 | 8 | Â | Â |
TNC | |||||
Positive | 27 | 15 | 12 | 13.788 | 0.001a |
Negative | 23 | 2 | 21 | Â | Â |